WellDyne’s Post

On World Parkinson's Disease Day, Dr. Vishal Sehgal, President of Portea Medical, has penned down an article for BW Healthcare World. Gain essential insights into Parkinson's symptoms, treatment options, and the latest advancements in research. Click here to read more - https://bit.ly/3xCrXrf #ParkinsonsAwareness #HealthcareInnovation #PorteaMedical #BWHealthcareWorld #NeurologicalHealth #ResearchAdvancements #TreatmentOptions #WorldParkinsonsDay #NeurologyAwareness #MedicalInsights Meena Ganesh Ganesh Krishnan Vaibhav Tewari Aswin Kumar K M Ramasubramani Ganesan Poonam Valvatkar Darshith Satheesh Surendar Chauhan

People live with Inflammatory Rheumatic Conditions, suffering silently undiagnosed for years until it is too late to achieve remission; their quality of life has deteriorated, and their contribution to society is impeded. Building a long-term strategy for holistic care and access to timely treatment of these is an investment and not a cost. Find more evidence in the insightful report we launched today at the #EULAR2024 in Vienna.

Today GAfPA launched a landmark report: The Value of Achieving Remission in Inflammatory Arthritis Evidence Glossary.   The document provides for the first time a full picture of 🌍 the global clinical, social and economic impact of inflammatory rheumatic conditions 💙 the value of achieving remission for patient wellbeing.   Learn more here: https://lnkd.in/dfDc2jcM   #EULAR2024 #valueofremission #rheumaticcondition 

Proud to have worked with #GAfPA, #OPENHealth, and both clinical and patient experts to create a glossary of evidence that underscores the need for urgent action in inflammatory rheumatic conditions. The consequences of a delayed diagnosis and suboptimal treatment are significant, not only for the individual but also for society at large, particularly due to patients finding themselves in a position where they need to retire early. There is clear evidence that acting early is cost-effective. “What societies do not spend on health, on prevention, on ability, they will spend on disability.” To learn more 👉 https://lnkd.in/dfDc2jcM #valueofremission #EULAR2024

What are the prevalence, risk factors, clinical features, and outcomes of influenza-associated pulmonary aspergillosis in critically ill patients? Read the full research in the March issue: https://hubs.la/Q02nJJV50 #JournalCHEST #MedEd

Our latest report on Parkinson's disease dives into the growing need for innovative therapies and support systems for those affected by this condition. With medical research and technology advancing, there are more opportunities now than ever to enhance the quality of life for patients. Stay ahead of the curve and see how the Parkinson's disease market is evolving here: https://lnkd.in/dPsrRhPp #FutureMarketInsights #Parkinsons #Healthcare

📚🌟 Debunking the Myth: "Chronic disease medications are only meant to manage symptoms, not cure the condition." 🔍 Fact Check: The landscape of medical research has evolved, bringing hope and progress to patients with chronic conditions! Advances in science and innovation have led to the development of medications that go beyond symptom management. 💡 The Truth: Many chronic disease medications are designed to do much more than provide relief from symptoms. They can slow down the progression of the condition, prevent complications, and significantly enhance the overall quality of life for patients. 🌱 Embracing the Possibilities: At Medford, we believe in the power of cutting-edge medical solutions. Our commitment is to offer you the latest, most effective medications that aim to make a real difference in your health journey. #MythBusters#ChronicDiseaseMedications#AdvancesInMedicine#QualityOfLife#EmbracingPossibilities

Imagine a world where screening all U.S. residents over 35 for chronic kidney disease could enhance life expectancy, reduce the need for dialysis or transplant, and deliver excellent value in healthcare spending. That's precisely what Stanford Medicine researchers have uncovered. Lead author Marika Cusick emphasizes the silent nature of CKD until its late stages, making early detection crucial. Screening opens the door to early diagnosis, treatment, and improved life expectancy, ultimately curbing the risk of progressing to deadly and costly late-stage kidney disease. 🔍 Dive deeper into this groundbreaking study below. It's time to revolutionize kidney health screening for a healthier future! 💙🌐 #KidneyHealthScreening #HealthcareAdvancements #EarlyDetection #EmpowerHealth https://lnkd.in/gpA9gPYZ

Capabilities that impact one of the most prominent chronic disease states (#diabetes) across our veteran population.The Diasyst platform improves provider access to clinical data in #telehealth #connectedcare #primarycare and allows veterans to share real time metrics (#remotepatientmonitoring) on their #healthandwellness. Streamlined care, with dashboards to reduce the "information safari" for providers, while enabling environments of care that support the VA mission. #missioncritical

Hyperkalemia is dangerous for patients with heart and kidney issues. Stay informed on the latest developments and evidence-based recommendations with this Study Brief, ensuring effective management and improved patient outcomes. Access Free Course Now: https://ow.ly/WMP850PWrp7